{
    "2020-10-13": [
        [
            {
                "time": "2020-Q3",
                "original_text": "生物制品行业专题研究：2020年Q3疫苗批签发报告 - Q3批签发环比、同比大幅提升 流感、肺炎疫苗等表现强劲",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "流感",
                        "肺炎",
                        "Q3"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【盛·动态】长盛基金旗下多只产品净值创新高",
                "features": {
                    "keywords": [
                        "长盛基金",
                        "净值创新高"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业日报：严防二波疫情反复 板块行情反弹",
                "features": {
                    "keywords": [
                        "医药生物",
                        "疫情反复",
                        "板块反弹"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国泰君安国际】速评|信达国际(1801.HK)：达伯华IBI301获批上市",
                "features": {
                    "keywords": [
                        "信达国际",
                        "达伯华",
                        "IBI301",
                        "获批上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物：目前公司新冠疫苗处于研发过程中",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "新冠疫苗",
                        "研发"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-13",
                "original_text": "10月13日午盘两市净流入前20股(名单)",
                "features": {
                    "keywords": [
                        "两市净流入",
                        "名单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "流感疫苗上演一票难求行情？紧俏热销背后乱象频生",
                "features": {
                    "keywords": [
                        "流感疫苗",
                        "一票难求",
                        "乱象"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "生物疫苗早盘快速走强 瑞普生物涨逾9%",
                "features": {
                    "keywords": [
                        "生物疫苗",
                        "瑞普生物",
                        "涨逾9%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-Q3",
                "original_text": "【天风医药 | 专题】2020年Q3血制品批签发报告：整体批签发增长，单季度国产白蛋白占比提升",
                "features": {
                    "keywords": [
                        "血制品",
                        "批签发",
                        "白蛋白",
                        "Q3"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块冲高，复星医药、康希诺-U、智飞生物、天坛生物、华兰生物普涨",
                "features": {
                    "keywords": [
                        "疫苗板块",
                        "复星医药",
                        "康希诺-U",
                        "智飞生物",
                        "天坛生物",
                        "华兰生物",
                        "普涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中泰证券：新冠病毒疫苗即将进入兑现期 建议关注康泰生物等",
                "features": {
                    "keywords": [
                        "新冠病毒疫苗",
                        "兑现期",
                        "康泰生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：关注三季报业绩主线",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "业绩主线"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}